The novel coronavirus disease (COVID-19) pandemic remains a global public health crisis,
presenting a broad range of challenges. To help address some of the main problems, the …

In the middle of November 2021, Omicron (B. 1.1. 529), a novel variant of SARS-CoV-2 was
identified in South Africa. Owing to continuous increasing cases with rapid transmissibility …

Detailed characterisation of immune responses induced by COVID-19 vaccines rolled out in
India: COVISHIELDTM (CS) and COVAXIN®(CO) in a pre-exposed population is only …

The COVID-19 disease continues to cause devastation for almost 3 years of its identification.
India is one of the leading countries to set clinical trials, production, and administration of …

Background Historically, a critical aetiological agent of health concern stays till eternity after
its discovery, so shall it be with the COVID‐19 outbreak. It has transformed human life to a …

One of the most significant medical advancements in human history is the development of
vaccines. Progress in vaccine development has always been greatly influenced by scientific …

COVID-19 will be a continuous threat to human population despite having a few vaccines at
hand until we reach the endemic state through natural herd immunity and total immunization …

Background India started its vaccination programme for Coronavirus-19 infection (COVID-
19) on 16 January 2021 with CovishieldTM (Oxford/Astra Zeneca vaccine manufactured by …

Kidney transplant candidates and kidney transplant recipients (KTRs) are at particular risk of
severe complications of COVID-19 disease. In Western countries, mortality in affected …

Vaccination against coronavirus disease-19 (COVID-19) is effective in preventing the
occurrence or reduction in the severity of the infection. Patients with inflammatory bowel …